Skip to main content
FinSpry Logo
FinSpry
INCY logo
INCY
(NASDAQ)
Incyte Corporation
$116.69-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Incyte Corporation (INCY) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Incyte Corporation stock.

Analyst Consensus Rating

Investment consensus from 24 professional research analysts

Consensus Rating

Buy
Based on 24 unique analysts
(42 total ratings in last 90 days)
Very High Confidence∞:1 Buy/Sell

Average Price Target

$117.00
↑ 0.27% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest INCY Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Mitchell Kapoor
HC Wainwright
BuyReiterates
$140.00
Salveen Richter
Goldman Sachs
HoldMaintains
$100.00
Etzer Darout
Barclays
BuyMaintains
$117.00 → $134.00
Judah Frommer
Morgan Stanley
HoldMaintains
$103.00
Matt Phipps
William Blair
HoldMaintains
-
Evan Seigerman
BMO Capital
HoldMaintains
$94.00 → $112.00
Brian Abrahams
RBC Capital
HoldMaintains
$95.00 → $99.00
Srikripa Devarakonda
Truist
HoldMaintains
-
Mitchell Kapoor
HC Wainwright
BuyReiterates
$140.00
Etzer Darout
Barclays
BuyMaintains
$117.00
Ashwani Verma
UBS
HoldMaintains
$103.00 → $113.00
Ashwani Verma
UBS
HoldMaintains
$103.00 → $113.00
Marc Frahm
TD Cowen
BuyMaintains
$124.00
Evan Seigerman
BMO Capital
HoldUpgrades
$75.00 → $94.00
Salim Syed
Mizuho
BuyMaintains
$121.00
Derek Archila
Wells Fargo
HoldMaintains
$135.00 → $101.00
Stephen Willey
Stifel Nicolaus
BuyMaintains
$123.00
Michael Schmidt
Guggenheim
BuyMaintains
$130.00 → $136.00
Matt Phipps
William Blair
HoldMaintains
-
Salveen Richter
Goldman Sachs
HoldMaintains
$100.00
Tazeen Ahmad
BofA Securities
BuyMaintains
$124.00
Judah Frommer
Morgan Stanley
HoldMaintains
$103.00
Matt Phipps
William Blair
HoldMaintains
-
Google Biotechnology
TipRanks - Google
BuyReiterates
$121.00 → $118.00
PerPlexity Biotechnology
TipRanks - PerPlexity
BuyReiterates
$121.00 → $118.00
Anthropic Biotechnology
TipRanks - Anthropic
BuyReiterates
$114.00 → $112.00
DeepSeek Biotechnology
TipRanks - DeepSeek
BuyReiterates
$120.00
xAi Biotechnology
TipRanks - xAI
BuyReiterates
$122.00 → $118.00
OpenAI Biotechnology
TipRanks - OpenAI
BuyReiterates
$119.00 → $118.00
Mitchell Kapoor
HC Wainwright
BuyReiterates
$135.00 → $140.00
Stephen Willey
Stifel Nicolaus
BuyMaintains
$123.00
Mitchell Kapoor
HC Wainwright
BuyReiterates
$135.00 → $140.00
Allison Bratzel
Piper Sandler
BuyMaintains
$110.00
Srikripa Devarakonda
Truist
HoldMaintains
-
Evan Seigerman
BMO Capital
SellReiterates
$75.00
Ashwani Verma
UBS
HoldMaintains
$94.00 → $103.00
Judah Frommer
Morgan Stanley
HoldMaintains
$103.00
Ashwani Verma
UBS
HoldMaintains
$94.00 → $103.00
Jay Olson
Oppenheimer
HoldMaintains
$90.00 → $107.00
Stephen Willey
Stifel
Strong BuyMaintains
$120.00 → $123.00
Jay Olson
Oppenheimer
HoldMaintains
$84.00 → $90.00
Brian Abrahams
RBC Capital
HoldMaintains
$95.00

Frequently Asked Questions

What is the analyst consensus rating for INCY?

The analyst consensus rating for INCY is "Buy" based on 24 analyst recommendations.

What is the average price target for INCY?

The average 12-month price target for INCY is $117.00, representing an upside of 0.3% from the current price of $116.69.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.